We are live on
!
Find out more
CCMD
Cypress Capital Management (Delaware) Portfolio holdings
AUM
$539M
1-Year Est. Return
11.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.98%
1 Year Est. Return
-11.57%
3 Year Est. Return
+25.57%
5 Year Est. Return
+231.18%
10 Year Est. Return
–
AUM
$727M
AUM Growth
-$7.03M
(-0.96%)
Cap. Flow
-$70.9M
Cap. Flow
% of AUM
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
27.83%
Holding
176
New
5
Increased
26
Reduced
90
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Motors
GM
|
+$7.43M |
| 2 |
Pfizer
PFE
|
+$6.07M |
| 3 |
Booking.com
BKNG
|
+$5.25M |
| 4 |
Analog Devices
ADI
|
+$2.26M |
| 5 |
Dow Inc
DOW
|
+$2.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$15.7M |
| 2 |
PNC Financial Services
PNC
|
+$14M |
| 3 |
Coca-Cola
KO
|
+$3.79M |
| 4 |
Danaher
DHR
|
+$3.48M |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$3.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Healthcare | 13.49% |
| 3 | Financials | 10.66% |
| 4 | Communication Services | 10.38% |
| 5 | Consumer Discretionary | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bristol-Myers Squibb
BMY
$132B
| $306K | 0.04% |
4,844
-851
| -15% | -$52.9K |
|
152
Zoetis
ZTS
$30B
| $306K | 0.04% |
1,945
+240
| +14% | +$38K |
|
153
International Paper
IP
$22B
| $297K | 0.04% |
5,808
| – | – |
|
154
AstraZeneca
AZN
$250B
| $295K | 0.04% |
+2,964
| New | +$298K |
|
155
Air Products & Chemicals
APD
$67.6B
| $288K | 0.04% |
1,025
| – | – |
|
156
Lowe's Companies
LOW
$125B
| $271K | 0.04% |
1,423
| – | – |
|
157
AbbVie
ABBV
$435B
| $270K | 0.04% |
2,495
+44
| +2% | +$4.71K |
|
158
Philip Morris
PM
$295B
| $269K | 0.04% |
3,026
+54
| +2% | +$4.59K |
|
159
iShares Core MSCI Europe ETF
IEUR
$9.17B
| $266K | 0.04% |
4,930
| – | – |
|
160
iShares Biotechnology ETF
IBB
$9.71B
| $248K | 0.03% |
1,650
| – | – |
|
161
Target
TGT
$68B
| $233K | 0.03% |
+1,174
| New | +$220K |
|
162
Stryker
SYK
$130B
| $231K | 0.03% |
950
| – | – |
|
163
Travelers Companies
TRV
$80.2B
| $222K | 0.03% |
1,473
| – | – |
|
164
Eli Lilly
LLY
$1.06T
| $221K | 0.03% |
1,185
-339
| -22% | -$66.3K |
|
165
Cigna
CI
$74.6B
| $220K | 0.03% |
+909
| New | +$203K |
|
166
M&T Bank
MTB
$36.2B
| $219K | 0.03% |
1,445
-328
| -18% | -$48.4K |
|
|
SWAV
167
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $210K | 0.03% |
+1,612
| New | +$193K |
|
168
SPDR Gold Trust
GLD
$142B
| $202K | 0.03% |
1,260
| – | – |
|
169
SIGA Technologies
SIGA
$219M
| $81K | 0.01% |
12,500
| – | – |
|
170
Automatic Data Processing
ADP
$108B
| – | – |
-4,128
| Closed | -$727K |
|
171
Advanced Micro Devices
AMD
$789B
| – | – |
-2,725
| Closed | -$250K |
|
172
CVS Health
CVS
$122B
| – | – |
-10,035
| Closed | -$685K |
|
173
General Dynamics
GD
$106B
| – | – |
-2,460
| Closed | -$366K |
|
174
iShares Russell 3000 ETF
IWV
$20.4B
| – | – |
-1,385
| Closed | -$310K |
|
175
SiriusXM
SIRI
$10.1B
| – | – |
-1,555
| Closed | -$99K |
|
Similar funds
KPW
SIMS
RTS
KCM
MG
SMG
HPWM
RWA
Cypress Capital Management (Delaware)'s Q1 2021 Portfolio in Review
As of Q1 2021, Cypress Capital Management (Delaware) held 176 positions worth $727M, down 0.96% from $734M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Cypress Capital Management (Delaware) withdrew a net $70.9M in Q1 2021, closing 6 positions and reducing 90 holdings. Its most notable exit was Automatic Data Processing, an estimated $727K position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Cypress Capital Management (Delaware) opened a new position in Broadridge worth $2.03M.
- Cypress Capital Management (Delaware)'s largest Q1 2021 buy was Broadridge: 13,240 shares worth $2.03M.
- Cypress Capital Management (Delaware) added most to General Motors in Q1 2021, an estimated $7.43M increase.
- Cypress Capital Management (Delaware)'s biggest Q1 2021 reduction was Abbott, cutting an estimated $15.7M.
- Cypress Capital Management (Delaware) fully exited Automatic Data Processing in Q1 2021, selling an estimated $727K.
- Cypress Capital Management (Delaware)'s ten largest holdings make up 28% of its $727M portfolio in Q1 2021.
- Cypress Capital Management (Delaware) opened 5 new positions and closed 6 in Q1 2021.
- Cypress Capital Management (Delaware)'s portfolio value fell 0.96% quarter-over-quarter to $727M.
Based on Cypress Capital Management (Delaware)'s 13F filing for Q1 2021, filed 12 May 2021.